Baker Biotech Capital III (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital III (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital III (GP), LLC. Baker Biotech Capital III (GP), LLC is a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a 10% Owner in GENOMIC HEALTH INC ($GHDX).
Address: 667 MADISON AVENUE 17TH FLOOR NEW YORK 10021 NY
Companies in which Baker Biotech Capital III (GP), LLC is an Insider
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital III (GP), LLC: 10% Owner
Holdings: 88,559 shares
Latest Transaction: Feb 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Biotech Capital III (GP), LLC: 10% Owner
Holdings: 252,529 shares
Current Value: $6,942,022
Latest Transaction: Oct 06 2005
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital III (GP), LLC: Director
Holdings: 228,556 shares
Current Value: $13,893,919
Latest Transaction: May 04 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Biotech Capital III (GP), LLC
Sentiment: All, IBPI, GHDX, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2006 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 3.35 | 52,661 | 176,414 | 88,559 | 35.9 K to 88.6 K (+146.70 %) |
| Oct 06 2005 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | C | 0.00 | 335,085 | 0 | 0 | |
| Oct 06 2005 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 12.00 | 136,316 | 1,635,792 | 252,529 | 116.2 K to 252.5 K (+117.30 %) |
| Oct 06 2005 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | J | 0.00 | 4,518 | 0 | 116,213 | 111.7 K to 116.2 K (+4.04 %) |
| Oct 06 2005 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | C | 0.00 | 111,695 | 0 | 111,695 | 0 to 111.7 K |
| Jul 19 2005 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 3.50 | 34,642 | 121,247 | 35,898 | 1.3 K to 35.9 K (+2,758.12 %) |
| May 04 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.00 | 75,070 | 300,280 | 228,556 | 153.5 K to 228.6 K (+48.91 %) |
View all Baker Biotech Capital III (GP), LLC insider transactions.